Received Oct 10, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEPA | HEP A (HAVRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | 3J9G4 | — |
a vaccine for Havrix, the Hep A vaccine, it was expired on 30-Aug-2025 and it was given to a patient; This non-serious case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 19-year-old female patient who received HAV (Havrix) (batch number 3J9G4, expiry date 30-AUG-2025) for prophylaxis. On 23-SEP-2025, the patient received Havrix. On 23-SEP-2025, an unknown time after receiving Havrix, the patient experienced expired vaccine used (Verbatim: a vaccine for Havrix, the Hep A vaccine, it was expired on 30-Aug-2025 and it was given to a patient). The outcome of the expired vaccine used was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 23-SEP-2025 A Primary care supervisor had a vaccine for Havrix, the Hepatitis A vaccine, it was expired on 30th August 2025, and it was given to a patient on 23rd September 2025 which led to expired vaccine used.